Navigation Links
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Date:7/24/2012

effects of their current opioid. 

Relmada Therapeutics is led by an experienced management team.  CEO Sergio Traversa PharmD, MBA has over twenty-five years of experience in the healthcare sector in the United States and Europe, ranging from management positions in the major pharmaceutical industry at Eli Lilly where he participated in the launch of Prozac and the early development of Zyprexa®, Strattera® and Cymbalta®, and Johnson & Johnson where he held the position of Area Manager for Southern Europe of Therakos Inc., a cancer and immunology division of the company, to investing and strategic advisory roles at leading healthcare focused financial institutions such as Mehta and Isaly, Merlin BioMed and Rx Capital.

Najib Babul, PharmD, is the President and Chief Scientific Officer of Relmada with over twenty years of experience in analgesic drug development.  Dr. Babul was V.P., Global Clinical Drug Development and Therapeutic Leader, Analgesia & Rheumatology at Scirex Corporation (now Premier Research), and Director, Clinical Research at Purdue Pharma.  He has designed studies and is an author on publications on MS Contin®, OxyContin®, Avinza®, Ultram® ER, Opana® ER, Codeine Contin®, sustained release hydromorphone and Dyloject®.  He is also Chair of the American Pain Society's Clinical Trials Special Interest Group and sits on the editorial board of the Journal of Opioid Management.

Danny Kao, PhD, JD, is Consulting Senior Vice President, Pharmaceutical Development of Relmada and has extensive formulation development experience.  He has developed a number of marketed extended release opioid dosage forms, including NDAs (New Drug Applications) and first to file ANDAs (Abbreviated New Drug Applications) and he has more than 20 issued or pending pa
'/>"/>

SOURCE Relmada Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 2015 , ... A new host-based therapy for Ebola, anthrax ... Graduate Institute and its collaborators. The discovery has the potential to speed to ... August 27 by Scientific Reports, an open access research journal from the publishers ...
(Date:9/1/2015)... San Francisco, CA (PRWEB) , ... September 01, ... ... software tools, today announced the release of a groundbreaking new version of its ... GenoCAD’s rule-based design methodology breaks down complex DNA sequences into numerous genetic parts, ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Global Supply Chain Resiliency ... and resiliency practitioners with luminaries and thought leaders to advance the professional discipline ... their innovations and performance excellence. At that time its principle sponsor, Resilinc ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... industries because of its properties such as low carbon footprints and compostability. These ... use of petroleum based plastics. On the basis of applications, the market for ...
Breaking Biology Technology:Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 4GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 4Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 5
... NEW YORK, April 18, 2011 KellBenx, a biotechnology ... (NIPD) of genetic and inherited disorders, announced today that ... Medical Center to research a new blood test that ... pregnancy – or even before women become pregnant. Preterm ...
... no larger than viruseshave been constructed through a revolutionary ... Liu and their colleagues at Arizona State University,s Biodesign ... construct arbitrary, two and three-dimensional shapes, mimicking those commonly ... ultimately find their way into a wide array of ...
... Carmell Therapeutics, a company that manufactures novel blood plasma-based ... closed on a Series A financing it will use ... for early clinical validation for the Company,s first products. ... Light Capital Partners, a private investment firm that invests ...
Cached Biology Technology:KellBenx Secures Worldwide Agreement With Cedars-Sinai Medical Center for Biomarker Technology to Predict Premature Births 2New DNA nanoforms take shape 2New DNA nanoforms take shape 3New DNA nanoforms take shape 4Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics 2Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics 3
(Date:8/19/2015)... Aug. 19, 2015  VOXX International Corporation (Nasdaq: ... entered into a Definitive Agreement to purchase the ... authentication market leader EyeLock through an acquiring entity.  ... a controlling interest in the acquiring entity. The ... of due diligence.  Expanding on its existing supply ...
(Date:8/12/2015)... Florida , August 12, 2015 ... pace of mobile payment innovation and advanced biometrics technology ... replace the way consumers rely on using their credit ... with reinventing the future for payment services led by ... NXTD ), :  Google, Inc. (NASDAQ: GOOG ...
(Date:8/10/2015)... The latest 364 page report from ... the global border security market . Visiongain ... 2015. Now: Border security is hard to achieve ... business critical issue you need to know about - and ... analysis of how this will impact your company and the ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... patient society representatives gathered in Valencia, Spain for the ... Osteoporosis Patient Societies. Osteoporosis is a widespread ... as many as one in two women and one ... International Osteoporosis Foundation (IOF) CEO Patrice McKenney stated, ...
... has awarded one of this year,s ERC Advanced Grants ... well-established research in the field of biosilicates with prize ... is professor at Mainz University,s Institute of Physiological Chemistry. ... and production of genetically engineered enzymes (silicateins) that allow ...
... March 17, 2011 (BRONX, NY) Researchers at ... discovered that members of an enzyme family found in humans ... role in regulating cell motility. Their findings suggest an entirely ... metastatic cancer. , David Sharp, Ph.D. , associate professor ...
Cached Biology News:Enzyme can steer cells or possibly stop them in their tracks 2
... GeneMarker software has been designed and ... with a biologist friendly genotyping analysis tool. ... several research groups into the software. Their ... accuracy, flexibility and low acquisition cost. ...
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens....
... OLIGO is a multi-functional program ... oligonucleotides from a sequence file ... DNA sequencing, site-directed mutagenesis, and ... hybridization temperature and secondary structure ...
... a revolutionary new application for DNA ... novel interface, Expression makes complex computational ... Expression uses the very latest computing ... the way sequences are analysed. Features ...
Biology Products: